GlassScriptPhysician profile
Scott R Caesar
NPI 1083849566
$20,291.93
in general payments reported to CMS, 2019-2025
46 companies · $3,243 in 2025
The $3,243 reported for 2025 was more than what 87% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,139 · 2020: $970 · 2021: $3,828 · 2022: $4,294 · 2023: $3,273 · 2024: $1,545 · 2025: $3,243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,221 · Travel and Lodging: $671 · Education: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,221.17 |
| Travel and Lodging | $671.23 |
| Education | $167.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $6,501.52 | 2021-2025 | Urolift, Barrigel |
| Neotract INC. | $1,991.89 | 2019-2020 | |
| Boston Scientific Corporation | $1,896.15 | 2019-2025 | Axonics, Spectra, General - Therapies |
| Janssen Biotech, INC. | $1,839.72 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Valencia Technologies Corporation | $1,187.18 | 2023-2025 | Ecoin Device Kit |
| Laborie Medical Technologies Corp. | $843.04 | 2019-2025 | |
| Axonics, INC. | $621.18 | 2020-2024 | Axonics, Bulkamid |
| Bayer Healthcare Pharmaceuticals INC. | $582.42 | 2022-2025 | |
| Astellas Pharma US INC | $398.35 | 2019-2024 | Xtandi |
| Procept Biorobotics Corporation | $383.38 | 2022-2023 | Aquabeam Robotic System |
| Endo Pharmaceuticals INC. | $367.45 | 2019-2024 | Edex, Xiaflex, Aveed |
| C. R. Bard, INC. & Subsidiaries | $365.83 | 2022-2023 | Bard Urinary Drainage Bag |
| Sumitomo Pharma America, INC. | $304.09 | 2023-2025 | Gemtesa |
| Antares Pharma, INC. | $241.99 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Calyxo, INC. | $231.30 | 2025 | Cvac Aspiration System |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $202.84 | 2024-2025 | Adstiladrin |
| Pfizer INC. | $154.80 | 2019-2025 | |
| Medtronic USA, INC. | $137.47 | 2019-2020 | |
| Abbvie INC. | $134.30 | 2019-2025 | Botox |
| Olympus America INC. | $131.15 | 2023-2024 | Itind System |
| Bioprotect Medical, INC. | $130.25 | 2024-2025 | Bioprotect Balloon Implant System |
| Tolmar Pharmaceuticals, INC. | $123.13 | 2021-2022 | |
| Coloplast Corp | $121.50 | 2019-2025 | |
| Tolmar, INC. | $113.91 | 2023-2024 | |
| Medtronic, INC. | $103.82 | 2021-2023 | Interstim |
| Tempus Ai, INC | $103.45 | 2024-2025 | Xt Cdx |
| Urogen Pharma, INC. | $102.25 | 2022-2025 | |
| Karl Storz Endoscopy-America | $97.00 | 2019 | |
| Accord Healthcare, INC. | $89.92 | 2022-2025 | |
| Dendreon Pharmaceuticals LLC | $87.24 | 2019-2025 | Provenge |
| Myriad Genetic Laboratories, INC. | $84.55 | 2021-2022 | |
| Allergan, INC. | $81.96 | 2019-2021 | |
| Urovant Sciences INC | $81.44 | 2022 | |
| Progenics Pharmaceuticals, INC. | $67.88 | 2023-2024 | Pylarify |
| Endo USA, INC. | $67.05 | 2024-2025 | Xiaflex, Aveed, Edex |
| Halozyme INC | $53.86 | 2023 | |
| Merck Sharp & Dohme LLC | $38.65 | 2023 | Lynparza, Keytruda |
| Amgen INC. | $37.40 | 2019-2020 | |
| Convatec INC. | $37.40 | 2023 | |
| Kerecis Limited | $33.34 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Blue Earth Diagnostics | $25.05 | 2025 | Posluma |
| Novartis Pharmaceuticals Corporation | $22.59 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $21.24 | 2024 | Imfinzi |
| 180 Medical, INC. | $18.51 | 2024 | Cure Catheter |
| Immunitybio, INC. | $17.74 | 2025 | |
| Mission Pharmacal Company | $14.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Caesar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.